Declaration of Helsinki puts global justice up front
BMJ 2024; 387 doi: https://doi.org/10.1136/bmj.q2405 (Published 01 November 2024) Cite this as: BMJ 2024;387:q2405- Julian Sheather, ethics consultant
- London, UK
- juliansheather{at}gmail.com
Anybody who has undertaken research involving human participants knows that research ethics has to square some challenging circles. Medical research can be dangerous, even deadly. Improperly conducted it can be disastrous—the thalidomide tragedy ushered in the UK Committee on the Safety of Drugs and the 1968 Medicines Act. We must protect participants. But we must also facilitate essential medical research. Covid-19 vaccines are one of many examples of the benefits that rapid research can bring.
Getting the balance right between protection and facilitation is not easy. Bureaucracy and what some perceive to be excessive regulation are often cited as impediments to essential research.1 And there is always a danger that a proper alertness to ethical issues throughout the research cycle decays into regulatory compliance and the ticking of boxes.
The Declaration of Helsinki is one of the jewels in the World Medical Association’s (WMA) ethical crown. First developed in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.